DrReposER ID |
PDB |
Ligand |
Organism |
Macromolecule |
Pfam |
Res. |
Interface |
HETATM |
3H6T_A_CYZA265 |
3h6t |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
11 |
ILE C 92LYS A 104PRO A 105MET A 107SER A 108SER C 217LYS C 218LEU A 239SER A 242LEU A 247LYS A 251 |
CYZ A 265
|
3H6T_B_CYZB265 |
3h6t |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
9 |
LYS B 104PRO B 105MET B 107SER B 108LEU B 239SER B 242LEU B 247ASP B 248LYS B 251 |
CYZ B 265
|
3H6T_C_CYZC265 |
3h6t |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
11 |
ILE A 92LYS C 104PRO C 105MET C 107SER C 108SER A 217LYS A 218LEU C 239SER C 242LEU C 247LYS C 251 |
CYZ C 265
|
3IJX_B_HCZB800 |
3ijx |
HCZ DB00999(Hydrochlorothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE D 92LYS B 104PRO D 105PRO B 105SER D 108SER B 108SER D 217GLY D 219LEU B 239SER B 242 |
HCZ B 800
|
3IJX_D_HCZD800 |
3ijx |
HCZ DB00999(Hydrochlorothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
9 |
ILE B 92LYS D 104PRO D 105PRO B 105SER D 108SER B 108SER B 217LEU D 239SER D 242 |
HCZ D 800
|
3IJX_H_HCZH800 |
3ijx |
HCZ DB00999(Hydrochlorothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
5 |
LYS H 104PRO H 105SER H 108LEU H 239SER H 242 |
HCZ H 800
|
3IK6_B_HCZB262 |
3ik6 |
HCZ DB00999(Hydrochlorothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE B 92LYS E 104PRO B 105SER E 108SER B 108SER B 217LYS B 218GLY B 219LEU E 239SER E 242 |
HCZ B 262
|
3IK6_B_HCZB800 |
3ik6 |
HCZ DB00999(Hydrochlorothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE E 92LYS B 104PRO E 105SER E 108SER B 108SER E 217LYS E 218GLY E 219LEU B 239SER B 242 |
HCZ B 800
|
3IK6_H_HCZH800 |
3ik6 |
HCZ DB00999(Hydrochlorothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
4 |
LYS H 104SER H 108LEU H 239SER H 242 |
HCZ H 800
|
3ILT_B_TRUB800 |
3ilt |
TRU DB01021(Trichlormethiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
12 |
ILE E 92LYS B 104PRO B 105MET B 107SER B 108SER E 217LYS E 218LEU B 239SER B 242LEU B 247ASP B 248LYS B 251 |
TRU B 800
|
3ILT_E_TRUE800 |
3ilt |
TRU DB01021(Trichlormethiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE B 92LYS E 104PRO E 105MET E 107SER E 108SER B 217LEU E 239SER E 242LEU E 247LYS E 251 |
TRU E 800
|
3ILT_H_TRUH800 |
3ilt |
TRU DB01021(Trichlormethiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
3 |
ILE H 92SER H 108SER H 217 |
TRU H 800
|
3ILU_B_HFZB800 |
3ilu |
HFZ DB00774(Hydroflumethiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE E 92LYS B 104PRO B 105PRO E 105SER E 108SER B 108SER E 217GLY E 219LEU B 239SER B 242 |
HFZ B 800
|
3ILU_E_HFZE800 |
3ilu |
HFZ DB00774(Hydroflumethiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
11 |
ILE B 92LYS E 104PRO E 105PRO B 105SER E 108SER B 108SER B 217LYS B 218GLY B 219LEU E 239SER E 242 |
HFZ E 800
|
3ILU_H_HFZH800 |
3ilu |
HFZ DB00774(Hydroflumethiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
5 |
LYS H 104PRO H 105SER H 108LEU H 239SER H 242 |
HFZ H 800
|
3LSF_B_PZIB800 |
3lsf |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
10 |
TYR B 35PRO E 105PRO B 105MET B 107SER B 108SER E 217GLY E 219SER B 242LEU B 247ASP B 248 |
PZI B 800
|
3LSF_B_PZIB802 |
3lsf |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
3 |
SER B 217ASP E 248ASN E 252 |
PZI B 802
|
3LSF_E_PZIE800 |
3lsf |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
10 |
PRO E 105PRO B 105MET E 107SER E 108SER B 108GLY B 219SER E 242LEU E 247ASP E 248LYS E 251 |
PZI E 800
|
3LSF_E_PZIE802 |
3lsf |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
3 |
SER E 217ASP B 248ASN B 252 |
PZI E 802
|
3LSF_H_PZIH800 |
3lsf |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
None |
8 |
TYR H 35PRO H 105MET H 107SER H 108SER H 242LEU H 247ASP H 248LYS H 251 |
PZI H 800
|
3LSL_A_PZIA800 |
3lsl |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
7 |
TYR A 35MET A 107SER D 217ASN A 242LEU A 247ASP A 248LYS A 251 |
PZI A 800
|
3LSL_A_PZIA801 |
3lsl |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
8 |
ILE A 92PRO D 105PRO A 105SER D 108SER A 108SER A 217GLY A 219ASN D 242 |
PZI A 801
|
3LSL_A_PZIA802 |
3lsl |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
3 |
SER D 217ASP A 248ASN A 252 |
PZI A 802
|
3LSL_D_PZID800 |
3lsl |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
7 |
TYR D 35MET D 107SER A 217ASN D 242LEU D 247ASP D 248LYS D 251 |
PZI D 800
|
3LSL_D_PZID801 |
3lsl |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
8 |
ILE D 92PRO D 105PRO A 105SER D 108SER A 108SER D 217GLY D 219ASN A 242 |
PZI D 801
|
3LSL_D_PZID802 |
3lsl |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
NonePF10613(Lig_chan-Glu_bd) |
3 |
SER A 217ASP D 248ASN D 252 |
PZI D 802
|
3LSL_G_PZIG800 |
3lsl |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
None |
6 |
TYR G 35MET G 107ASN G 242LEU G 247ASP G 248LYS G 251 |
PZI G 800
|
3LSL_G_PZIG801 |
3lsl |
PZI DB09210(Piracetam) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
None |
3 |
PRO G 105SER G 108ASN G 242 |
PZI G 801
|
3TKD_A_CYZA266 |
3tkd |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
14 |
ILE B 92LYS A 104PRO A 105PRO B 105MET A 107SER A 108SER B 217LYS B 218GLY B 219LEU A 239SER A 242LEU A 247ASP A 248LYS A 251 |
CYZ A 266
|
3TKD_B_CYZB267 |
3tkd |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
14 |
ILE A 92LYS B 104PRO A 105PRO B 105MET B 107SER B 108SER A 217LYS A 218GLY A 219LEU B 239SER B 242LEU B 247ASP B 248LYS B 251 |
CYZ B 267
|
5L1F_A_6ZPA902 |
5l1f |
6ZP DB08883(Perampanel) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF00060(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
8 |
SER A 516ASP A 519PRO A 520TYR A 616PHE A 623SER B 785SER A 788ASN A 791 |
6ZP A 902
|
5L1F_B_6ZPB902 |
5l1f |
6ZP DB08883(Perampanel) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
9 |
SER B 510SER B 516ASP B 519PRO B 520TYR B 616LEU B 620PHE B 623SER B 790ASN B 791 |
6ZP B 902
|
5L1F_C_6ZPC902 |
5l1f |
6ZP DB08883(Perampanel) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
7 |
SER C 516ASP C 519PRO C 520TYR C 616PHE C 623SER C 788ASN C 791 |
6ZP C 902
|
5L1F_D_6ZPD902 |
5l1f |
6ZP DB08883(Perampanel) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
10 |
SER D 516PHE D 517ASP D 519PRO D 520TYR D 616ASN D 619LEU D 620PHE D 623SER D 788ASN D 791 |
6ZP D 902
|
5WEO_A_CYZA1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE D 481PRO A 494PRO D 494MET A 496SER A 497SER D 497SER D 729GLY D 731ASP A 760LYS A 763 |
CYZ A1302
|
5WEO_B_CYZB1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
no annotation |
9 |
ILE C 481PRO C 494PRO B 494MET B 496SER B 497SER C 729GLY C 731ASP B 760LYS B 763 |
CYZ B1302
|
5WEO_C_CYZC1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
no annotation |
9 |
PRO C 494PRO B 494MET C 496SER B 497SER C 497SER B 729GLY B 731ASP C 760LYS C 763 |
CYZ C1302
|
5WEO_D_CYZD1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
9 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729GLY A 731ASP D 760LYS D 763 |
CYZ D1302
|
6DLZ_A_CYZA1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DLZ_B_CYZB1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DLZ_C_CYZC1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DLZ_D_CYZD1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM0_A_CYZA1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM0_B_CYZB1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729GLY C 731LEU B 751LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM0_C_CYZC1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM0_D_CYZD1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
PRO A 494MET D 496SER D 497SER A 729GLY A 731LEU D 751LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM1_A_CYZA1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM1_B_CYZB1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM1_C_CYZC1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM1_D_CYZD1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM2_A_CYZA1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM2_B_CYZB1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM2_C_CYZC1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM2_D_CYZD1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE A 481PRO A 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|